News EdiGene and Arbor Biotechnologies Announce Worldwide Non-exclusive License Agreement to Advance Ex Vivo Engineered Cell Therapy Programs Feb 11, 2022
News EdiGene Enters Research Collaboration to Develop Gene-editing Therapies for Inherited Retinal Degeneration with Peking Union Medical College Hospital Feb 11, 2022
News EdiGene Enters Strategic R&D Collaboration with Haihe Laboratory of Cell Ecosystem to Develop Hematopoietic Stem Cell Regenerative Therapies and Platform Technologies Feb 11, 2022
News Global Drug Pricing and Market Access: What to Expect in 2022 Feb 09, 2022 Posted by Sidley Austin
News InSphero Further Strengthens Scientific Advisory Board for Liver Diseases by Appointing Professor Nikolai Naoumov Feb 09, 2022
News Medical Device Companies Take Note: FDA’s Proposed Rule to Align ISO 13485 With its Quality System Regulation Moves Forward Feb 07, 2022 Posted by Sidley Austin
